Merrimack Pharmaceuticals, Inc.Cambridge, MA United States
Company Description
Merrimack Pharmaceuticals takes a technological approach to fighting cancer. A biopharmaceutical company, Merrimack develops oncology drugs using its proprietary Network Biology technology, which combines biological data and computer-based modeling to discover and develop candidates. The company has four candidates in clinical stage development, including a chemotherapy drug to treat pancreatic and gastric cancer and antibody therapies designed to inhibit the growth of cancerous cells. It also has a fifth candidate in its pipeline in preclinical stages of development. Tracing its roots back to the early 1990s, Merrimack became a public company in 2012.
| 1 Kendall Square, Suite B7201 | Phone: 617-441-1000 | http://www.merrimackpharma.com |
| Cambridge, MA 02139 | Fax: 617-491-1386 | 
Map This Company |
| United States |
Try a Full Premium Subscription
Access over 85 million companies
Call (866) 443-3939 or
Prepare for your Sales call
Try a Small Business Subscription
Starting $89 per month
Merrimack Pharmaceuticals, Inc. Rankings
Executives
| 24 executives listed for Merrimack Pharmaceuticals, Inc.'s Cambridge, MA location. | ||
| Chairman | Gary Crocker | |
|---|---|---|
| President, CEO, and Director | Robert Mulroy | |
| CFO and Treasurer | WilliamSullivan | |
Financials
| Company Type | Public - NASDAQ: MACK Single Location |
|---|---|
| Fiscal Year-End | December |
| 2011 Employees | 218 |
DNBiLeverage D&B's credit assessment tools to positively impact
your business. Get the scoop on Merrimack Pharmaceuticals, Inc. now.
- Reduce risk.
- Drive greater profitability.
- Increase cash flow.
